Evaluation of calgranulin B in stools from the patients with colorectal cancer

Diseases of the Colon and Rectum

Volumn 51, Issue 11, 2008, Pages 1703-1709

  Yoo, Byong Chul ^a   Shin, Young Kyoung ^a,b   Lim, Seok Byung ^a   Hong, Sung Hye ^a,b   Jeong, Seung Yong ^a   Park, Jae Gahb ^b  

^a National Cancer Center   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Calgranulin B; Colorectal cancer; Proteomics; Stool

Indexed keywords

CALGRANULIN B; HEMOGLOBIN;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADULT; AGED; BIOLOGICAL MARKERS; CALGRANULIN A; CALGRANULIN B; COLORECTAL NEOPLASMS; FECES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS;

EID: 54949157266     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-008-9381-6     Document Type: Article

References (23)

1. RJ Davies R Miller N Coleman 2005 Colorectal cancer screening: prospects for molecular stool analysis Nat Rev Cancer 5 199 209
2. ER Fearon B Vogelstein 1990 A genetic model for colorectal tumorigenesis Cell 61 759 67
3. JM Rhodes 2000 Colorectal cancer screening in the UK: Joint Position Statement by the British Society of Gastroenterology, The Royal College of Physicians, and The Association of Coloproctology of Great Britain and Ireland Gut 46 746 8
4. O Kronborg M Ugstad P Fuglerud 2000 Fecal calprotectin levels in a high risk population for colorectal neoplasia Gut 46 795 800
5. WG Brydon SS Campbell NA Anderson 2001 Fecal calprotectin levels and colorectal neoplasia Gut 48 579 80
6. AB Shitrit D Braverman H Stankiewics 2007 Fecal calprotectin as a predictor of abnormal colonic histology Dis Colon Rectum 50 2188 93
7. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag, 2002.
8. YK Shin BC Yoo HJ Chang 2005 Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance Cancer Res 65 3162 70
9. DA Ahlquist JA Gilbert 1996 Stool markers for colorectal cancer screening: future considerations Dig Dis 14 132 44
10. NK Osborn DA Ahlquist 2005 Stool screening for colorectal cancer: molecular approaches Gastroenterology 128 192 206
11. AG Roseth MK Fagerhol E Aadland 1992 Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study Scand J Gastroenterol 27 793 8
12. R Dubrow CS Kim AK Eldred 1992 Fecal lysozyme: an unreliable marker for colorectal cancer Am J Gastroenterol 87 617 21
13. R Dubrow L Yannielli 1992 Fecal protein markers of colorectal cancer Am J Gastroenterol 87 854 8
14. T Nakayama H Yasuoka T Kishino 1987 ELISA for occult fecal albumin Lancet 1 1368 9
15. AG Roseth J Kristinsson MK Fagerhol 1993 Fecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 28 1073 6
16. E Aadland MK Fagerhol 2002 Fecal calprotectin: a marker of inflammation throughout the intestinal tract Eur J Gastroenterol Hepatol 14 823 5
17. H Ton Ø Brandsnes S Dale 2000 Improved assay for fecal calprotectin Clin Chim Acta 292 41 54
18. UL Fagerberg L Loof U Myrdal 2005 Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms J Pediatr Gastroenterol Nutr 40 450 5
19. J Kristinsson CH Armbruster M Ugstad 2001 Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics Scand J Gastroenterol 36 202 7
20. CB Summerton MG Longlands K Wiener DR Shreeve 2002 Fecal calprotectin: a marker of inflammation throughout the intestinal tract Eur J Gastroenterol Hepatol 14 841 5
21. PJ Limburg ME Devens JJ Harrington 2003 Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia Am J Gastroenterol 98 2299 305
22. G Hoff T Grotmol E Thiis-Evensen 2004 Testing for fecal calprotectin (PhiCal) in the Norwegian colorectal cancer prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT) Gut 53 1329 33
23. RA Newton N Hogg 1998 The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils J Immunol 160 1427 35